Onur Boyman, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus (NCT03312335) | Onur Boyman, MD | 2018-08-08 |
Track Onur Boyman, MD automatically
Every clearance here is in the API, with alerts when new ones post.